Compare WALD & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WALD | INFU |
|---|---|---|
| Founded | 1988 | 2005 |
| Country | United Kingdom | United States |
| Employees | 364 | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.3M | 194.8M |
| IPO Year | N/A | 2005 |
| Metric | WALD | INFU |
|---|---|---|
| Price | $1.66 | $9.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $2.00 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 664.0K | 266.9K |
| Earning Date | 03-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | $9.89 | $3.20 |
| Revenue Next Year | $4.31 | $7.31 |
| P/E Ratio | ★ N/A | $193.80 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $0.72 | $5.43 |
| 52 Week High | $3.22 | $11.04 |
| Indicator | WALD | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 53.69 |
| Support Level | $1.47 | $8.59 |
| Resistance Level | $1.95 | $10.04 |
| Average True Range (ATR) | 0.14 | 0.48 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 55.00 | 62.72 |
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.